BD

Bhupendra Devi Prasad Tiwari

Active Director Director DIN 10921088
DIN 10921088 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhupendra Devi Prasad Tiwari

Data last updated:

Bhupendra Devi Prasad Tiwari is a Director at Unibeck Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 10921088
Primary Designation Director
Industry Pharma
First Appointment 24 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unibeck Pharma Private Limited U46497MH2025PTC438833
Director24 Jan 20252025Active

Board colleagues of Bhupendra Devi Prasad Tiwari

NameDINCompanyDesignation
Jitendra Deviprasad Tiwari10921089Unibeck Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Unibeck Pharma Private Limited
Premium access

Shareholding and investment profile for Bhupendra Devi Prasad Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhupendra Devi Prasad Tiwari

Bhupendra Devi Prasad Tiwari currently holds 1 directorship: Unibeck Pharma Private Limited (Director, since 24 Jan 2025).

Bhupendra Devi Prasad Tiwari was first appointed on 24 Jan 2025 as Director at Unibeck Pharma Private Limited.

The current boards of Bhupendra Devi Prasad Tiwari's companies include Jitendra Deviprasad Tiwari (Unibeck Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available